×
Stock Screener
Stock Research
Top Dividend Stocks
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Estrella Immunopharma Income Statement 2021-2025 | ESLA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Income Statement
Balance Sheet
Cash Flow Statement
Key Financial Ratios
Format: Annual
Format: Quarterly
Format: Annual
View Annual Reports
Loading...
Annual Data | Millions of US $ except per share data
2024-06-30
2023-06-30
2022-12-31
2021-12-31
2021-06-30
Revenue
-
-
-
-
-
Cost Of Goods Sold
-
-
-
-
-
Gross Profit
-
-
-
-
-
Research And Development Expenses
$4.109
$10.451
-
-
-
SG&A Expenses
$3.201
$0.663
-
-
$0.249
Other Operating Income Or Expenses
-
-
$-1.57
$-0.249
-
Operating Expenses
-
-
-
-
-
Operating Income
$-7.31
$-11.114
$-1.57
$-0.249
$-0.249
Total Non-Operating Income/Expense
-
-
$0.654
$0.001
-
Pre-Tax Income
$-7.31
$-11.114
$-0.916
$-0.248
$-0.249
Income Taxes
$0.002
-
$0.081
-
-
Income After Taxes
$-7.312
$-11.114
$-0.996
$-0.248
$-0.249
Other Income
-
-
-
-
-
Income From Continuous Operations
$-7.312
$-11.114
$-0.996
$-0.248
$-0.249
Income From Discontinued Operations
-
-
-
-
-
Net Income
$-7.312
$-11.114
$-0.308
$-1.792
$-0.248
EBITDA
$-7.31
$-11.114
$-1.57
$-0.249
$-0.249
EBIT
$-7.31
$-11.114
$-1.57
$-0.249
$-0.249
Basic Shares Outstanding
27
0
1
1
-
Shares Outstanding
27
0
1
1
-
Basic EPS
$-0.27
$-36.35
$-0.22
$-1.52
-
EPS - Earnings Per Share
$-0.27
$-36.35
$-0.22
$-1.52
-
www.jqwidgets.com